Study guide

Substance disorders and alcohol withdrawal

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Substance disorders and alcohol withdrawal

Key Takeaways Explain This Topic AI

Severe alcohol withdrawal can cause seizures and delirium.

CIWA-Ar is unsuitable for some delirious or non-communicative patients.

Benzodiazepine treatment needs clinical monitoring rather than a score alone.

Last updated: October 2026

Substance Use Disorders & Acute Withdrawal Syndromes

Substance misuse and acute withdrawal syndromes account for a substantial burden of acute admissions across Australian emergency departments, general medical units, and addiction medicine services. Sound clinical knowledge of the neurobiological adaptations underlying drug dependence, the chronological progression of alcohol withdrawal states, and the pharmacology of detoxification and substitution therapies is vital for candidate success on the AMC examination.

Diagnostic Framework: DSM-5 Substance Use Disorders

The DSM-5 provides a unified diagnostic construct for Substance Use Disorders (SUD), replacing earlier distinctions between substance abuse and dependence with an 11-item criterion matrix categorized across four functional domains:

Important Clinical Caveat : Criteria 10 (tolerance) and 11 (withdrawal) are not counted toward a substance use disorder diagnosis if the medication is taken strictly under appropriate medical supervision (e.g., prescribed opioids for chronic cancer pain).

  • Alcohol Withdrawal: Neurobiology, Chronology & Management
  • Neurobiology and Pathophysiology

Alcohol is a potent central nervous system depressant. Its neurochemical effects involve two primary receptor systems:

GABA-A Receptors : Ethanol acts as a positive allosteric modulator of inhibitory GABA-A receptors, facilitating chloride influx and hyperpolarizing neuronal membranes. Chronic exposure results in compensatory downregulation and conformational desensitization of GABA-A receptors.

NMDA Glutamate Receptors : Ethanol acts as a negative allosteric modulator of excitatory NMDA (N-methyl-D-aspartate) glutamate receptors, suppressing excitatory neurotransmission. Chronic exposure induces compensatory upregulation and hypersensitization of NMDA receptors to preserve basal neuroexcitation.

Upon abrupt alcohol cessation, the inhibitory dampening is suddenly removed while the upregulated NMDA receptors are exposed to endogenous glutamate. The resulting neurochemical imbalance— GABA hypofunction coupled with glutamate excitotoxicity —leads to unrestrained neuronal firing, profound central sympathetic hyperarousal, autonomic hyperactivity, seizures, and excitotoxic neuronal death.

Clinical Phases of Alcohol Withdrawal

Minor Autonomic Hyperactivity (6 to 12 Hours) : Fine resting and postural tremor, profuse diaphoresis, tachycardia ( > 100 bpm > 100\text{ bpm} > 100 bpm ), systolic hypertension, anorexia, nausea, vomiting, insomnia, and psychomotor agitation.

Alcoholic Hallucinosis (12 to 48 Hours) : Perceptual abnormalities that may be auditory (voices, clicking), visual, or tactile (formication, sensation of insects under skin). Crucial AMC Diagnostic Distinction : Alcoholic hallucinosis occurs in a clear sensorium . The patient is alert, oriented to time, place, and person, and recognizes that their environment is real, differentiating this state from delirium.

Withdrawal Seizures ("Rum Fits") (24 to 48 Hours) : Generalized tonic-clonic seizures occurring as a solitary event or a brief cluster of 2 to 3 discrete seizures within hours. Electroencephalography is normal between episodes. Status epilepticus is rare ( < 3 % < 3\% < 3% ) and should prompt urgent search for concurrent intracranial pathology (subdural haematoma) or infection.

Delirium Tremens (DTs) (48 to 72+ Hours, peaking at 72-96 hours) : The most severe manifestation of withdrawal, carrying an untreated mortality rate of 5 − 15 % 5-15\% 5 − 15% . Characterized by:

Global clouding of consciousness and delirium : Severe disorientation, fluctuating alertness, and profound agitation.

Autonomic instability : Severe hyperpyrexia (temperature > 38.5 ∘ C > 38.5^\circ\text{C} > 38. 5 ∘ C ), marked resting tachycardia ( > 120 − 140 bpm > 120-140\text{ bpm} > 120 − 140 bpm ), labile severe hypertension, and drenching diaphoresis.

Coarse gross tremor and polymorphic visual/tactile hallucinations.

Medical Complications : Cardiovascular collapse, severe electrolyte derangements (hypokalaemia, hypomagnesaemia, hypophosphataemia), aspiration pneumonia, and cardiac arrhythmias.

Clinical Assessment: The CIWA-Ar Protocol

Withdrawal assessment: CIWA-Ar can guide symptom-triggered therapy in a communicative suitable patient. It is unreliable in delirium, intubation or major symptom confounding. High-risk cases can need fixed/loading regimens and higher-acuity monitoring; use the local addiction pathway and treat competing illness.

Score < 10 < 10 < 10 : Mild withdrawal; supportive care, quiet environment, oral hydration.

Score 10 − 19 10-19 10 − 19 : Moderate withdrawal; triggers medical pharmacotherapy with benzodiazepines.

Score ≥ 20 \ge 20 ≥ 20 : Severe withdrawal; aggressive benzodiazepine titration, high-acuity nursing observation.

Pharmacotherapy of Alcohol Withdrawal

Symptom-Triggered Benzodiazepine Regimen : Rather than fixed-dose schedules, Australian guidelines recommend symptom-triggered therapy, administering benzodiazepines only when the CIWA-Ar score is ≥ 10 \ge 10 ≥ 10 . This approach reduces the total duration of treatment and cumulative drug exposure.

Diazepam : The drug of choice in standard patients due to its rapid oral absorption and long-acting active metabolites (nordiazepam / desmethyldiazepam), which provide a smooth, "self-tapering" clinical effect. Typical regimen: diazepam 10 − 20 mg 10-20\text{ mg} 10 − 20 mg orally every 1 to 2 hours until the patient is calm and CIWA-Ar is < 10 < 10 < 10 .

Hepatic Impairment and the Elderly : In patients with decompensated chronic liver disease (cirrhosis, elevated INR, jaundice) or frail elderly patients, long-acting benzodiazepines accumulate, risking prolonged sedation and hepatic encephalopathy. In this cohort, short-acting agents directly metabolized by glucuronidation without active metabolites are mandatory: oxazepam 15 − 30 mg 15-30\text{ mg} 15 − 30 mg orally or lorazepam 1 − 2 mg 1-2\text{ mg} 1 − 2 mg orally/IV .

Wernicke's Encephalopathy and Korsakoff Syndrome

Wernicke's encephalopathy (WE) is an acute, life-threatening neuropsychiatric syndrome resulting from thiamine (vitamin B1) deficiency. Thiamine pyrophosphate is an obligatory cofactor for key enzymes in cerebral energy metabolism (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase). Thiamine deficiency leads to selective neuronal death in the mammillary bodies, thalamus, periaqueductal grey matter, and cerebellar vermis.

Primary references (checked 7 October 2026): Australian alcohol treatment guidance .